Anteris Technology提议2亿美元股票发行，计划投资美敦力

2026-01-21 05:07

Anteris Technologies Global (AVR) said on Tuesday that it plans to sell $200 million of common stock in a proposed underwritten public offering, with underwriters granted an option to buy up to an additional $30 million of shares.
Separately, the company said it has agreed to sell up to $90 million of common stock to Medtronic plc in a private placement at the public offering price, subject to minimum and maximum ownership thresholds.
Completion of the Medtronic investment is contingent on completion of the public offering.
Anteris said it intends to use the proceeds to support its clinical strategy, including advancement of its DurAVR transcatheter heart valve trial, expansion of manufacturing capabilities, research and development, and general corporate purposes.
AMEUF closed -0.0% at $5.7.
Source: Press Release

More on Anteris Technologies Global Corp.